Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model
Saved in:
| Main Authors: | Filip Stanicic, Vladimir Zah, Dimitrije Grbic, Debra De Angelo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556690/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model.
by: Filip Stanicic, et al.
Published: (2024-01-01) -
Healthcare costs and resource utilization of patients with chronic post-traumatic stress disorder: a retrospective US claims analysis of commercially insured patients
by: Filip Stanicic, et al.
Published: (2024-11-01) -
Treatment patterns and characteristics of patients with Post-Traumatic Stress Disorder (PTSD): A retrospective claims analysis among commercially insured population.
by: Filip Stanicic, et al.
Published: (2024-01-01) -
Methaemoglobinemia Induced by MDMA?
by: L. L. W. Verhaert
Published: (2011-01-01) -
Health care costs and service utilization in the first year following moderate to severe traumatic injury
by: Mari Storli Rasmussen, et al.
Published: (2024-12-01)